• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓脂肪细胞或其前体细胞在特发性再生障碍性贫血中是否具有致病作用?

Do bone marrow fat cells or their precursors have a pathogenic role in idiopathic aplastic anaemia?

作者信息

Islam A

机构信息

Department of Medical Oncology, Roswell Park Memorial Institute, Buffalo, New York 14263.

出版信息

Med Hypotheses. 1988 Apr;25(4):209-17. doi: 10.1016/0306-9877(88)90032-1.

DOI:10.1016/0306-9877(88)90032-1
PMID:3285144
Abstract

Idiopathic aplastic anaemia (AA), aplastic anaemia of unknown aetiology, is usually defined as marrow failure with fatty replacement of hemopoietic tissue and peripheral pancytopenia. The pathophysiology is largely unknown, though many mechanisms have been hypothesized. These include the absence of or defects in hemopoietic stem cells (HSC), abnormalities of the bone marrow (BM) microenvironment, immune system disorders and abnormalities of the regulatory factors that control hemopoiesis. The characteristic feature of AA is the replacement of hematopoietically active marrow by fat cells; however, the fat cells themselves have received little attention to date, and this apparent fatty marrow infiltration has been considered a secondary phenomenon. That the marrow fat cells in AA may be abnormal and may have a pathogenic role has never been considered. This communication, postulates that AA may result from an abnormal and excessive proliferation of marrow fat cells and the displacement of the hematopoietic tissue of the marrow; and that the resultant marrow failure could be a secondary phenomenon.

摘要

特发性再生障碍性贫血(AA),即病因不明的再生障碍性贫血,通常被定义为骨髓衰竭伴造血组织脂肪替代和外周全血细胞减少。尽管已经提出了许多机制,但病理生理学在很大程度上仍不清楚。这些机制包括造血干细胞(HSC)的缺失或缺陷、骨髓(BM)微环境异常、免疫系统紊乱以及控制造血的调节因子异常。AA的特征性表现是造血活跃的骨髓被脂肪细胞替代;然而,脂肪细胞本身迄今为止很少受到关注,这种明显的脂肪骨髓浸润一直被认为是一种继发性现象。AA中的骨髓脂肪细胞可能异常并可能具有致病作用这一点从未被考虑过。本通讯推测,AA可能是由于骨髓脂肪细胞异常过度增殖以及骨髓造血组织被取代所致;并且由此导致的骨髓衰竭可能是一种继发性现象。

相似文献

1
Do bone marrow fat cells or their precursors have a pathogenic role in idiopathic aplastic anaemia?骨髓脂肪细胞或其前体细胞在特发性再生障碍性贫血中是否具有致病作用?
Med Hypotheses. 1988 Apr;25(4):209-17. doi: 10.1016/0306-9877(88)90032-1.
2
Special Education: Aplastic Anemia.特殊教育:再生障碍性贫血。
Oncologist. 1996;1(3):187-189.
3
Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.骨髓微环境的改变可能引发造血功能缺陷:再生障碍性贫血、慢性髓系白血病与正常骨髓的比较。
Exp Hematol. 2017 Jan;45:56-63. doi: 10.1016/j.exphem.2016.09.009. Epub 2016 Sep 28.
4
Aplastic anaemia.再生障碍性贫血
Lancet. 2005;365(9471):1647-56. doi: 10.1016/S0140-6736(05)66515-4.
5
Pathogenesis of aplastic anemia.再生障碍性贫血的发病机制。
Hematology. 2019 Dec;24(1):559-566. doi: 10.1080/16078454.2019.1642548.
6
Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.免疫抑制治疗后再生障碍性贫血中CD34+c-kit+和CD34+38-造血前体细胞的缺乏
Am J Hematol. 1996 Aug;52(4):264-74. doi: 10.1002/(SICI)1096-8652(199608)52:4<264::AID-AJH5>3.0.CO;2-Q.
7
Current considerations of the etiology of aplastic anemia.再生障碍性贫血病因的当前思考
Crit Rev Oncol Hematol. 1985;4(1):1-30. doi: 10.1016/s1040-8428(85)80018-4.
8
[Progress in biology and therapy of aplastic anemia and other conditions of bone marrow failure].再生障碍性贫血及其他骨髓衰竭病症的生物学与治疗进展
Postepy Hig Med Dosw. 1992;46(1):21-51.
9
[Physiopathology of and therapy for aplastic anemia].
Nihon Naika Gakkai Zasshi. 2006 Sep 10;95(9):1851-7. doi: 10.2169/naika.95.1851.
10
Environmental factors in haemopoietic failure in humans.人类造血功能衰竭中的环境因素。
Ciba Found Symp. 1981;84:87-108. doi: 10.1002/9780470720660.ch6.

引用本文的文献

1
Differentiation of cancer cells upregulates HLA‑G and PD‑L1.癌细胞的分化会上调 HLA-G 和 PD-L1。
Oncol Rep. 2020 Jun;43(6):1797-1804. doi: 10.3892/or.2020.7572. Epub 2020 Apr 1.
2
The Phenotype and Functional Activity of Mesenchymal Stromal Cells in Pediatric Patients with Non-Malignant Hematological Diseases.儿科非恶性血液病患者间充质基质细胞的表型和功能活性。
Cells. 2020 Feb 12;9(2):431. doi: 10.3390/cells9020431.